PTC Therapeutics (PTCT): Navigating Regulatory Waters In Europe

In a recent development, the European Commission has chosen not to adopt the negative opinion put forth by the Committee for Medicinal Products for Human Use (CHMP) regarding the annual renewal of the conditional marketing authorization of Translarna (ataluren), a protein restoration therapy developed by PTC Therapeutics, Inc. This decision has had a significant impact […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.